Tag: genetic diagnostic

Claritas Is Example of New Lab Business Model

CEO SUMMARY: One by one, new business models for clinical laboratory testing are popping up. Each is a response to healthcare’s rapid evolution, the ongoing decline in lab test reimbursement, and the growing role for molecular diagnostics and genetic testing. In Cambridge, Massachusetts, Claritas Genomics, formerly the molecular lab at Boston Children’s Hospital, is one

View Article

January 22, 2013 “Intelligence: Late Breaking Lab News”

Not-for-profit Boston Children’s Hospital will have majority interest in a new lab testing company. Claritas Genomics will be based in Waltham, Massachusetts, and will develop genetic and molecular diagnostic testing solutions. Life Technologies Corporation is a partner in the new company. Boston Children’s Hospital is incorporating into Claritas the “expertise, assets and personnel of the

View Article

Lab Director Takes a Stand On Patented Genetic Testing

THIS LETTER APPEARED in the mailbag after our special intelligence briefing on how genetics will transform healthcare and before our look at how high-priced specialty esoteric testing is causing budget headaches for regional labs. (See TDRs, December 30, 2002 and January 20, 2003, respectively.)
Financial Pinch In Detroit
In Detroit, the 130 hospital laboratories participating in Joint

View Article

California Lab Regulators Are A Tough Bunch

CEO SUMMARY: By law, government regulators cannot comment publicly about the actions they take against the companies they regulate. That’s why the lab industry never learned that other public lab companies operating in California, following inspections by state authorities, were judged to have some deficiencies similar to those found at Specialty Laboratories.

BY NOW, JUST ABOUT

View Article

DIANON Systems, United Health, Aetna, Quest Diagnostics, Orchid, AmeriPath

DIANON SYSTEMS INKS NATIONAL AGREEMENT WITH UNITEDHEALTHCARE
A NEW NATIONAL AGREEMENT between DIANON Systems, Inc. and UnitedHealthcare was announced last week.

The agreement allows DIANON Systems to provide pathology and genetic testing services to all the beneficiaries in health plans offered by UnitedHealthCare, a division of UnitedHealth Group. It consolidates a number of existing agreements between the

View Article